Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 EUR)

NET PROFIT (x1000 EUR)

EMPLOYEES

Share

Scandinavian Biopharma Holding AB

Closing information (x1000 EUR)

Closing information 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Turnover 13,913 Less Arrow 10,944 Less Arrow 9,172
Financial expenses 1 More Arrow 46 Less Arrow 1
Earnings before taxes 62 Less Arrow 20 More Arrow 30
EBITDA -32 More Arrow 116 More Arrow 141
Total assets 11,218 Less Arrow 10,812 Less Arrow 10,333
Current assets 10,940 Less Arrow 10,635 Less Arrow 10,085
Current liabilities 10,148 Less Arrow 9,455 Less Arrow 8,990
Equity capital 1,070 More Arrow 1,357 Less Arrow 1,343
- share capital 23 Equal arrow 23 More Arrow 25
Employees (average) 30 Less Arrow 27 Less Arrow 25

Financial ratios

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Solvency 9.5% More Arrow 12.6% More Arrow 13.0%
Turnover per employee 464 Less Arrow 405 Less Arrow 367
Profit as a percentage of turnover 0.4% Less Arrow 0.2% More Arrow 0.3%
Return on assets (ROA) 0.6% Equal arrow 0.6% Less Arrow 0.3%
Current ratio 107.8% More Arrow 112.5% Less Arrow 112.2%
Return on equity (ROE) 5.8% Less Arrow 1.5% More Arrow 2.2%
Change turnover 2,937 Less Arrow 2,515 Less Arrow 1,189
Change turnover % 27% More Arrow 30% Less Arrow 15%
Chg. No. of employees 3 Less Arrow 2 More Arrow 6
Chg. No. of employees % 11% Less Arrow 8% More Arrow 32%

Total value of public sale

Fiscal year 2023/12 (consolidated) 2022/12 (consolidated) 2021/12 (consolidated)
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.